Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Cash from Financing Activities Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Cash from Financing Activities
AU$14.6m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Cash from Financing Activities
-AU$19.9m
CAGR 3-Years
21%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash from Financing Activities
AU$4.2m
CAGR 3-Years
-40%
CAGR 5-Years
9%
CAGR 10-Years
-17%
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash from Financing Activities
AU$95.1m
CAGR 3-Years
N/A
CAGR 5-Years
178%
CAGR 10-Years
38%
Probiotec Ltd
ASX:PBP
Cash from Financing Activities
-AU$11.1m
CAGR 3-Years
N/A
CAGR 5-Years
-1%
CAGR 10-Years
0%
Vita Life Sciences Ltd
ASX:VLS
Cash from Financing Activities
-AU$1.4m
CAGR 3-Years
29%
CAGR 5-Years
11%
CAGR 10-Years
4%

See Also

What is Arovella Therapeutics Ltd's Cash from Financing Activities?
Cash from Financing Activities
14.6m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Cash from Financing Activities amounts to 14.6m AUD.

What is Arovella Therapeutics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
13%

Over the last year, the Cash from Financing Activities growth was 170%. The average annual Cash from Financing Activities growth rates for Arovella Therapeutics Ltd have been 14% over the past three years , 13% over the past five years .

Back to Top